Dalal, A. A., Shah, M., D’Souza, A. O., Chaudhari, S., & Crater, G. (2012). Clinical and economic outcomes for patients initiating fluticasone propionate/salmeterol combination therapy (250/50 mcg) versus anticholinergics in a comorbid COPD/depression population. Dove Medical Press.
シカゴスタイル引用形Dalal, Anand A., Manan Shah, Anna O. D’Souza, Sham Chaudhari, , Glenn Crater. Clinical and Economic Outcomes for Patients Initiating Fluticasone Propionate/salmeterol Combination Therapy (250/50 Mcg) Versus Anticholinergics in a Comorbid COPD/depression Population. Dove Medical Press, 2012.
MLA引用形式Dalal, Anand A., et al. Clinical and Economic Outcomes for Patients Initiating Fluticasone Propionate/salmeterol Combination Therapy (250/50 Mcg) Versus Anticholinergics in a Comorbid COPD/depression Population. Dove Medical Press, 2012.